Trials / Conditions / Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8
Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8
5 registered clinical trials studyying Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advance NCT04391049 | NRG Oncology | Phase 1 |
| Active Not Recruiting | Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Eso NCT04460937 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes NCT04501913 | City of Hope Medical Center | — |
| Completed | Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes NCT04183218 | Mayo Clinic | — |
| Withdrawn | Nutritional Supplementation in Reducing Complications in Patients With Locally Advanced Esophageal Cancer Unde NCT04029857 | M.D. Anderson Cancer Center | Phase 3 |